Combination Synopsis-Solicitation for Commercial Purchases - IDEXX.docx

COMBO SYNOPSIS SOLICITATION FOR COMMERCIAL ITEMS

1. Class Code: Q301

2. NAICS Code: 541380

3. Subject: Sole Source – Blood smear sample analysis and consultation services for Quantity (Qty) one (1) year, and Qty one (1) additional option year.

4. Solicitation Number: W911QX24Q0272

5. Set-Aside Code: N/A

6. Response Date: Five (5) business days after posting due via email to the Primary Point of Contact listed in the https://SAM.gov webpage for this combined synopsis-solicitation.

7. Place of Delivery/Performance:

U.S. Army Research Laboratory

8.

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.

INTENT TO SOLICIT ONLY ONE SOURCE

The proposed contract action is for supplies or services for which the Government is soliciting and negotiating with only one source under the authority of FAR 13.106-1(b)(1)(i). The name of the company the Government intends to award a contract to is IDEXX Laboratories, Inc. at One IDEXX Dr, Westbrook, Maine 04092. This notice of intent is not a request for competitive proposals. However, the Government will consider all proposals received prior to the closing date and time of this solicitation

(ii) The solicitation number is W911QX24Q0272. This acquisition is issued as an Request For Quotation (RFQ).

(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2024-06, effective 30 July 2024.

(iv) The associated NAICS code is 541380. The small business size standard is $19,000,000.00.

(v) The following is a list of contract line item number(s) and items, quantities and units of measure, (including option(s), if applicable):

CLIN 0001 (Base Effort): Qty one (1) year of outsourced blood smear sample analysis services. Analysis to be performed monthly.

· Qty 1000 blood smear samples expected in the period of performance (10 September 2024 to 09 September 2025) CLIN 0002 (Base Effort): Qty one (1) year of consultation services pertaining to the experimental data sets. To be performed monthly.

· Qty forty (40) hours of Clinical Pathologist Support expected in the period of performance (10 September 2024 to 09 September 2025) CLIN 1001 (Option Effort): Qty one (1) year of outsourced blood smear sample analysis services. Analysis to be performed monthly.

· Qty 600 blood smear samples expected in the period of performance (10 September 2025 to 09 September 2026) CLIN 1002 (Option Effort): Qty one (1) year of consultation services pertaining to the experimental data sets. To be performed monthly.

· Qty forty (40) hours of Clinical Pathologist Support expected in the period of performance (10 September 2025 to 09 September 2026)

(vi) Description of requirements:

See attached PWS for an extended description of the Government’s requirements:

(vii) All contract deliverables and technical reports shall be delivered to U.S. Army Research Laboratory (ARL) located at the 6375 Johnson Rd, Aberdeen Proving Ground, MD. Acceptance shall be performed at US Army ARL located in Aberdeen Proving Ground, MD. The FOB point is the Destination.

(viii) The provision at 52.212-1, Instructions to Offerors – Commercial, applies to this acquisition. The following addenda have been attached to this provision: None.

(ix) The provision at FAR 52.212-2, Evaluation - Commercial Items is applicable to this acquisition. The specific evaluation criteria to be included in paragraph (a) of that provision are as follows: N/A

(x) Offerors shall include a completed copy of the provision at FAR 52.212-3 (with its Alternate I), Offeror Representations with its offer.

(xi) The clause at 52.212-4, Contract Terms and Conditions - Commercial Items, applies to this acquisition. The following addenda have been attached to this clause None.

(xii) The clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders - Commercial Items and the selected clauses listed in DFARS 212.301 Solicitation provisions and Contract Clauses for the Acquisition of Commercial Items, applies to this acquisition. The following additional FAR/DFARS clauses cited in this clause are applicable:

-52.204-10, REPORTING EXECUTIVE COMPENSATION AND FIRST-TIER SUBCONTRACT AWARDS (OCT 2018)

-52.204-27, PROHIBITION ON A BYTEDANCE COVERED APPLICATION (JUN 2023)

-52.209-6, PROTECTING THE GOVERNMENT’ INTEREST WHEN SUBCONTRACTING WITH CONTRACTORS DEBARRED, SUSPENDED, OR PROPOSED FOR DEBARMENT (NOV 2021)

-52.219-28, POST-AWARD SMALL BUSINESS PROGRAM REREPRESENTATION (SEP 2021)

-52.222-3, CONVICT LABOR (JUN 2003)

-52.222-19, CHILD LABOR--COOPERATION WITH AUTHORITIES AND REMEDIES (JAN 2022) (DEVIATION 2020-O0019)

-52.222-21, PROHIBITION OF SEGREGATED FACILITIES (APR 2015)

-52.222-26, EQUAL OPPORTUNITY (SEP 2016)

-52.222-36, AFFIRMATIVE ACTION FOR WORKERS WITH DISABILITIES (JUL 2014)

-52.222-50, COMBATING TRAFFICKING IN PERSONS (NOV 2021)

-52.225-13, RESTRICTIONS ON CERTAIN FOREIGN PURCHASES (JUN 2008)

-52.226-8, ENCOURAGING CONTRACTOR POLICIES TO BAN TEXT MESSAGING WHILE DRIVING (MAY 2024) -52.232-33, PAYMENT BY ELECTRONIC FUNDS TRANSFER—CENTRAL CONTRACTOR REGISTRATION (OCT 2018)

(xiii) The following additional contract requirement(s) or terms and conditions apply (full text of all FAR/DFARS clauses that contain fill-in information, as well as all local clauses, can be found in the attached Provisions and Clauses Full-Text document):

FAR Provisions:

-52.204-7, SYSTEM FOR AWARD MANAGEMENT (OCT 2018)

-52.204-16, COMMERCIAL AND GOVERNMENT ENTITY CODE REPORTING (AUG 2020)

-52.204-20, PREDECESSOR OF OFFEROR (AUG 2020)

-52.204-24, REPRESENTATION REGARDING CERTAIN TELECOMMUNICATIONS AND VIDEO SURVEILLANCE SERVICES OR EQUIPMENT (NOV 2021) -52.204-26, COVERED TELECOMMUNICATIONS EQUIPMENT OR SERVICES-REPRESENTATION (OCT 2020)

-52.217-5, EVALUATION OF OPTIONS (JUL 1990)

-52.252.-1, SOLICITATION PROVISIONS INCORPORATED BY REFERENCE (FEB 1998)

FAR/DFARS Clauses:

-52.204-13, SYSTEM FOR AWARD MANAGEMENT MAINTENANCE (OCT 2018)

-52.204-18, COMMERCIAL AND GOVERNMENT ENTITY CODE MAINTENANCE (AUG 2020)

-52.204-19, INCORPORATON BY REFERENCE OF REPRESENTATIONS AND CERTIFICATIONS (DEC 2014)

-52.217-9, OPTION TO EXTEND THE TERM OF THE CONTRACT (MAR 2000)

-52.232-39, UNEFORCEABILITY OF UNAUTHORIZED OBLIGATIONS (JUN 2013)

-52.243-1, CHANGES—FIXED PRICE (AUG 1987)

-52.247-34, F.O.B. DESTINATION (NOV 1991)

-52.252-2, CLAUSES INCORPORATED BY REFERENCE (FEB 1998)

-252.203-7000, REQUIREMENTS RELATING TO COMPENSATION OF FORMER DOD OFFICIALS (SEP 2011) -252.203-7002, REQUIREMENT TO INFORM EMPLOYEES OF WHISTLEBLOWER RIGHTS (SEP 2013)

-252.204-7000, DISCLOSURE OF INFORMATION (OCT 2016)

-252.204-7003, CONTROL OF GOVERNMENT PERSONNEL WORK PRODUCT (APR 1992)

-252.204-7012, SAFEGUARDING COVERED DEFENSE INFORMATION AND CYBER INCIDENT REPORTING (OCT 2016)

-252.211-7003, ITEM UNIQUE IDENTIFICATION AND VALUATION (MAR 2022)

-252.225-7007, PROHIBITION ON ACQUISITION OF CERTAIN ITEMS FROM COMMUNIST CHINESE MILITARY COMPANIES (DEC 2018)

-252.225-7048, EXPORT-CONTROLLED ITEMS (JUN 2013)

-*252.225-7055, REPRESENTATION REGARDING BUSINESS OPERATIONS WITH THE MADURO REGIME (MAY 2022) -252.225-7056, PROHIBITION REGARDING BUSINESS OPERATIONS WITH THE MADURO REGIME (JAN 2023) -*252.225-7059, PROHIBITION ON CERTAIN PROCUREMENTS FORM THE XINJIANG UYGHUR AUTONOMOUS REGION-REPRESENTATION (JUN 2023) -252.225-7060, PROHIBITION ON CERTAIN PROCUREMENTS FROM THE XINJIANG UYGHUR AUTONOMOUS REGION (JUN 2023) -252.232-7003, ELECTRONIC SUBMISSION OF PAYMENT REQUESTS AND RECEIVING REPORTS (JUN 2012)

-252.232-7006, WIDE AREA WORKFLOW PAYMENT INSTRUCTIONS (DEC 2018)

-252.232-7010, LEVIES ON CONTRACT PAYMENTS (DEC 2006)

-252.243-7001, PRICING OF CONTRACT MODIFICATIONS (DEC 1991)

Adelphi Local Instructions:

ACC - APG POINT OF CONTACT

TECHNICAL POINT OF CONTACT

*INTENT TO SOLICIT ONLY ONE SOURCE

TYPE OF CONTRACT

GOV INSPECTION AND ACCEPTANCE

TAX EXEMPTION CERT. (ARL)

RECEIVING ROOM REQUIREMENT – APG

EXERCISE OF OPTION

DFARS COMMERCIAL CLAUSES

*EXCEPTIONS IN PROPOSAL

*AWARD OF CONTRACT

*ADELPHI CONTR. DIVISION URL

*PAYMENT TERMS

(xiv) This acquisition is rated under the Defense Priorities and Allocations System (DPAS) as N/A.

(xv) The following notes apply to this announcement: The Government is contemplating a Commercial, Firm Fixed Price (FFP) Contract type for this requirement under the FAR Part 13 Simplified Acquisition Procedures (SAP). In accordance with FAR 32.003, contract financing cannot be provided for this acquisition.

(xvi) Offers are due on Five (5) business days after solicitation posting, by 11:59 AM Eastern Standard Time via email to Acquisition Specialist, Thomas Jurgens, thomas.c.jurgens@army.mil.

(xvii) For information regarding this solicitation, please contact Acquistion Specialist, Thomas Jurgens, 520-691-5394, thomas.c.jurgens.ctr@army.mil.

Contracting Officer:

Template last updated 9/8/2020 image1.emf

PWS_IDEXX.doc Performance Work Statement (PWS)

Blood Smear Sample Analysis Services

13 August 2024

C.1 Background:

The Special Projects Team (SPT) of the Biological & Biotechnology Sciences (BBS) Division requires the collaboration with IDEXX for blood sample analysis in support of a top priority project of Dr. Baker. IDEXX Reference Laboratory offers a wide variety of sample analysis for veterinary and research settings.

C.2 Objective:

The objective of this effort is to conduct complete blood count and lymphocyte analysis on our blood samples, with all results verified by a certified pathologist.

C.3 Requirements:

C.3.1 The Contractor shall complete the following sample analysis services for classification of Lymphocyte Morphology on a Blood Smear:

C.3.1.1 Routine Staining of Blood Smear:

· Preparation and staining of blood smear samples to facilitate microscopic examination.

· Anticipated to be 1000 samples in the base year, and 650 samples for option year one (1) (reference paragraph C.9.1).

C.3.1.2 Microscopy:

· Examination of the stained blood smear by an American College of Veterinary Pathologist (ACVP)-certified clinical pathologist.

· Classification of lymphocytes into two (2) categories:

· Unremarkable: Lymphocytes with scant clear cytoplasm, a clumped chromatin pattern, and no visible nucleolus.

· Reactive or Atypical: Lymphocytes with morphology that deviates from "unremarkable" criteria, as described above.

· Notation of any lymphocytes exhibiting very unusual morphology.

C.3.1.3 Exclusions: The following analyses and assessments are not included in this service:

· Standard five-part differential leukocyte count

· Assessment of the erythron

· Assessment of the platelet mass and morphology

· Data interpretation beyond the classification of lymphocytes

C.3.1.4 Calibration and Consultation:

· An initial pilot study for calibration between the Principal Investigator (PI) and the IDEXX clinical pathologist is recommended to ensure consistency and accuracy in the classification of lymphocytes.

· Consultation services for this calibration study are complementary and will be provided at no additional cost.

This detailed scope ensures that the specific needs for lymphocyte classification are met, while also providing a pathway for consistent and accurate results through the recommended calibration study.

C.3.2 The Contractor shall provide further consultation services (anticipated 40 hours per year base and option year one (1)) related to the experimental data sets, including (reference paragraph C.9.2):

· Interpretation of the data

· Biological and toxicological significance

· Descriptive statistics

· Correlation with clinical observations and anatomic pathology findings

C.4 Non-Personal Services:

ARL/ALC/GARRISON NON-PERSONAL SERVICES (JUL 2012)

The contractor, as an independent contractor and not as an agent of the Government, shall provide the necessary resources (except those furnished by the Government) to accomplish tasks of the type set forth in the PWS.

Contractor employees performing services under this contract shall be controlled, directed and always supervised by management personnel of the contractor. The contractor's management shall ensure that employees properly comply with the performance standards outlined in this PWS and as required by the contracting officer or the TPOC. Contractor employees shall perform independent of and without the supervision of any Government official. Actions of contractor employees may not be interpreted or implemented in any manner that results in any contractor employee creating or modifying Federal policy, obligating the appropriated funds of the U.S. Government, overseeing the work of Federal employees, providing direct personal services to any Federal employee or otherwise violating the prohibitions set forth in Parts 7.5 and 37.1 of the Federal Acquisition Regulation (FAR). The Government shall control access to the facility and shall perform the inspection and acceptance of completed work and tasks.

C.5 Place of Performance:

The blood smear sample analysis services required under this contract will be performed at the following location: Attn: Sample Receiving, IDEXX BioAnalytics, 2825 KOVR Drive, West Sacramento, CA 95605.

C.6. Period of Performance:

The period of performance of this contract will commence on 10 September 2024 and conclude on 09 September 2026. The performance period is anticipated to be 12-months, including the base period and any option periods if exercised.

Base Period

· Start Date: 10 September 2024

· End Date: 09 September 2025

Option Periods

The Government reserves the right to extend the term of the contract by exercising option periods. Each option period will have a duration of 12-months.

Option Period 1:

· Start Date: 10 September 2025

· End Date: 09 September 2026

C.7 Distribution Statement:

C.7.1 Distribution Statement A applicable to this PWS and any technical data/documentation generated during performance: Approved for public release; distribution is unlimited.

C.8 Anti-Terrorism (AT) – Operations Security (OPSEC) Requirements:

The following AT-OPSEC requirements apply: Not Applicable

C. 9 Deliverables:

The Government plans to send a batch on blood smear samples to IDEXX monthly. Upon each review, the Government requires a report showing the contractor’s findings. The requirements of this report are outlined in paragraph C.3 of this PWS.

All deliverables outlined in the PWS shall be completed and submitted in accordance with the timeline specified in the DD1423 located within Section J of the contract. Any deviations from the schedule shall be approved in writing by the Contracting Officer (KO).

C. 9.1 The Contractor is to perform Blood Smear Sample Analysis services on the samples provided by the Government monthly. This service includes (1) routine staining of a blood smear and (2) microscopy.

C. 9.2 The Contractor is to perform further consultation services pertaining to the experimental data sets, including interpretation of the data, biological and toxicological significance, descriptive statistics, correlation with clinical observations and anatomic pathology findings.

Contracting Officer:

image2.emf